V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001171 | 230000760 | 1.61 | 69 | Palliative (P) | 2016-03-28 | 2016-04-02 | Trial Unspecified | N | N | 230001484 | CAPECITABINE + OXALIPLATIN |
| 230001172 | 230000763 | 1.67 | null | Palliative (P) | 2016-07-10 | 2016-07-11 | Fluorouracil + Folinic Acid (Mayo) | 2 | N | 230001512 | CETUXIMAB + IRINOTECAN + MDG |
| 230001173 | 230000765 | 1.61 | 50.6 | Curative (C) | null | 2015-04-24 | Oxaliplatin + Modified de Gramont | 2 | null | 230001544 | OXALIPLATIN + MDG |
| 230001174 | 230000766 | 1.67 | 91.4 | Curative (C) | 2015-09-05 | 2015-09-12 | Capecitabine (14 day) + Irinotecan | N | N | 230001578 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001175 | 230000768 | 1.61 | null | Adjuvant (A) | 2016-02-29 | 2016-03-01 | FLUOROURACIL + OXALIPLATIN | N | N | 230001591 | CAPECITABINE + OXALIPLATIN |
| 230001176 | 230000769 | 1.8 | 100.2 | null | 2015-04-23 | 2015-04-24 | CVP R | null | null | 230001605 | CAPECITABINE + OXALIPLATIN |
| 230001177 | 230000770 | 1.79 | null | Palliative (P) | null | 2015-10-29 | Oxaliplatin + Modified de Gramont | N | N | 230001616 | BEVACIZUMAB + CAPECITABINE |
| 230001178 | 230000771 | 1.75 | 76.8 | Palliative (P) | 2014-11-02 | 2014-11-22 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 230001616 | CAPECITABINE + IRINOTECAN |
| 230001179 | 230000772 | 1.57 | 76.2 | Adjuvant (A) | 2014-09-05 | 2014-09-22 | TRASTUZUMAB | N | null | 230001693 | TRIFLURIDINE + TIPIRACIL |
| 230001180 | 230000773 | 1.73 | 145.8 | Curative (C) | 2015-11-07 | 2015-11-07 | Trastuzumab 21 day maintenance | 99 | N | 230001733 | CISPLATIN + GEMCITABINE |
| 230001181 | 230000774 | 1.72 | 76 | Palliative (P) | 2015-10-19 | 2016-04-25 | Capecitabine + Oxaliplatin 14day | N | N | 230001757 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001182 | 230000776 | 1.64 | null | Palliative (P) | 2018-03-11 | 2018-03-18 | Irinotecan + Modified De Gramont | N | N | 230001759 | TEMOZOLOMIDE |
| 230001183 | 230000777 | 1.57 | 74.5 | Neo-adjuvant (N) | 2017-12-04 | 2017-12-05 | FLUOROURACIL + OXALIPLATIN | N | null | 230001850 | OXALIPLATIN + RALTITREXED |
| 230001184 | 230001343 | 1.65 | 74.8 | Palliative (P) | 2015-08-14 | 2015-08-14 | PACLITAXEL | N | N | 230001971 | CARBOPLATIN + PEMETREXED |
| 230001185 | 230000778 | 0 | null | Adjuvant (A) | 2017-06-30 | 2017-06-30 | FEC | 02 | N | 230002040 | CAPECITABINE |
| 230001186 | 230000779 | 1.67 | 60.4 | Adjuvant (A) | 2015-12-23 | 2015-12-24 | Irinotecan + Modified De Gramont | 02 | N | 230002091 | OXALIPLATIN + MDG |
| 230001187 | 230000780 | 1.54 | null | Curative (C) | 2015-09-21 | 2015-09-21 | Oxaliplatin + Modified de Gramont | N | Y | 230002091 | OXALIPLATIN + MDG |
| 230001188 | 230000781 | null | 97.6 | null | null | 2018-05-17 | R GCVP | N | N | 230002108 | PACLITAXEL |
| 230001189 | 230000782 | 1.59 | null | Curative (C) | 2014-02-21 | 2014-02-21 | Irinotecan + Modified De Gramont | N | null | 230002226 | CAPECITABINE + OXALIPLATIN |
| 230001190 | 230000783 | 1.73 | null | Adjuvant (A) | null | 2017-10-28 | BEVACIZUMAB + FLUOROURACIL | N | N | 230002231 | CAPECITABINE + OXALIPLATIN |
| 230001191 | 230001347 | 1.86 | 97.5 | Palliative (P) | null | 2015-04-15 | Fluorouracil + Folinic Acid Weekly | N | N | 230002268 | OXALIPLATIN + MDG |
| 230001192 | 230000784 | 1.73 | 87 | Palliative (P) | 2013-01-07 | 2013-04-28 | CAPECITABINE + OXALIPLATIN | 02 | N | 230002469 | CAPECITABINE |
| 230001193 | 230000787 | 1.74 | 89.1 | Disease modification (D) | 2015-02-17 | 2015-02-25 | R GCVP | 2 | null | 230002573 | OXALIPLATIN + MDG |
| 230001194 | 230000788 | 1.8 | null | Curative (C) | 2015-02-07 | 2015-02-19 | Cabazitaxel | N | null | 230002610 | CAPECITABINE + OXALIPLATIN |
| 230001195 | 230000790 | 1.7 | 98.9 | Adjuvant (A) | 2018-07-28 | 2018-08-04 | Fluorouracil + Folinic Acid Weekly | N | N | 230002610 | OXALIPLATIN + MDG |
| 230001196 | 230000793 | 1.59 | 82.3 | Curative (C) | 2014-05-28 | 2014-05-28 | Capecitabine + Oxaliplatin 21day | N | null | 230002682 | OXALIPLATIN + MDG |
| 230001197 | 230000794 | 1.53 | 56.6 | Palliative (P) | 2018-05-17 | 2018-05-25 | Capecitabine | 02 | N | 230002702 | OXALIPLATIN + MDG |
| 230001198 | 230000795 | 1.81 | 91.4 | Palliative (P) | 2016-11-06 | 2016-11-11 | Doxorubicin + Ifosfamide | N | N | 230002716 | FLUOROURACIL |
| 230001199 | 230000797 | 1.53 | null | Adjuvant (A) | 2016-12-13 | 2016-12-16 | Docetaxel | 02 | N | 230002716 | FEC |
| 230001200 | 230001350 | 1.64 | 64.7 | Palliative (P) | 2018-09-16 | 2018-09-16 | FLUOROURACIL + OXALIPLATIN | 2 | Y | 230002744 | CAPECITABINE + IRINOTECAN |
| 230001201 | 230000799 | 0 | 60 | Neo-adjuvant (N) | 2017-12-19 | 2018-02-11 | Docetaxel 100mg/m2 (21 day) | N | N | 230002819 | OXALIPLATIN + MDG |
| 230001202 | 230001351 | 1.63 | 69 | Adjuvant (A) | 2014-06-17 | 2014-07-21 | Irinotecan + Modified De Gramont | 2 | N | 230002819 | OXALIPLATIN + MDG |
| 230001203 | 230000802 | 1.83 | 94.3 | Palliative (P) | null | 2016-10-30 | LENVATINIB | null | null | 230002985 | CETUXIMAB + IRINOTECAN + MDG |
| 230001204 | 230000803 | 1.66 | 97.6 | Adjuvant (A) | 2014-04-19 | 2014-05-07 | Irinotecan | N | N | 230003007 | OXALIPLATIN + MDG |
| 230001205 | 230000804 | 1.78 | 92.65 | Adjuvant (A) | 2015-05-21 | 2015-05-24 | Irinotecan + Modified De Gramont | N | N | 230003102 | OXALIPLATIN + MDG |
| 230001206 | 230001585 | 1.6 | 73.3 | Not known (9) | 2016-07-23 | 2016-09-08 | Rituximab | N | null | 230003313 | FLUOROURACIL |
| 230001207 | 230000805 | null | 112.5 | Adjuvant (A) | 2016-09-29 | 2016-10-24 | Cetuximab + FOLFIRI cycle 2 onwards | N | Y | 230003331 | OXALIPLATIN + MDG |
| 230001208 | 230000807 | 1.59 | null | Palliative (P) | 2016-04-29 | 2016-04-29 | Bendamustine+Rituximab(Sub Courses) | N | N | 230003338 | OXALIPLATIN + MDG |
| 230001209 | 230000808 | 1.7 | 89 | Palliative (P) | 2013-10-01 | 2013-11-05 | Bevacizumab + Capecitabine | 02 | N | 230003340 | TRIFLURIDINE + TIPIRACIL |
| 230001210 | 230001353 | 1.63 | 68.7 | Adjuvant (A) | 2012-11-11 | 2013-04-21 | VANDETANIB | 2 | N | 230003454 | CAPECITABINE + OXALIPLATIN |
| 230001211 | 230000810 | 1.59 | 69.3 | Palliative (P) | null | 2017-07-17 | Bortezomib + Cyclophos + Dex | 2 | N | 230003507 | IRINOTECAN |
| 230001212 | 230000811 | 1.57 | 63 | Palliative (P) | 2014-10-04 | 2015-12-17 | FLUOROURACIL + IRINOTECAN | N | null | 230003531 | CAPECITABINE + OXALIPLATIN |
| 230001213 | 230000812 | null | 46.7 | Palliative (P) | 2014-10-20 | 2014-11-02 | FEC 100 + DOCETAXEL | N | N | 230003539 | OXALIPLATIN + MDG |
| 230001214 | 230000812 | 1.53 | 84.8 | Palliative (P) | 2018-02-28 | 2018-02-28 | Irinotecan + Modified De Gramont | N | N | 230003539 | CETUXIMAB |
| 230001215 | 230000812 | null | null | Palliative (P) | 2014-01-29 | 2014-02-08 | Oxaliplatin + Modified de Gramont | Y | N | 230003539 | CETUXIMAB + IRINOTECAN + MDG |
| 230001216 | 230000813 | null | 58 | Curative (C) | 2017-06-14 | 2017-10-08 | IBRUTINIB | N | N | 230003642 | CAPECITABINE + OXALIPLATIN |
| 230001217 | 230000814 | 1.85 | 76.8 | Palliative (P) | 2016-03-13 | 2016-04-05 | Carboplatin AUC 2 - 5 | N | N | 230003741 | CAPECITABINE |
| 230001218 | 230000815 | 1.7 | 71.6 | Adjuvant (A) | 2018-12-23 | 2019-01-06 | CARBOPLATIN + ETOPOSIDE | 02 | N | 230003771 | OXALIPLATIN + MDG |
| 230001219 | 230000816 | 1.81 | 102.6 | Palliative (P) | 2017-04-11 | 2017-04-29 | BEVACIZUMAB + FLUOROURACIL | N | N | 230003771 | BEVACIZUMAB + CAPECITABINE |
| 230001220 | 230000817 | 1.71 | 57.75 | Neo-adjuvant (N) | 2019-02-28 | 2019-03-07 | Fluorouracil + Folinic Acid Weekly | 02 | N | 230003846 | OXALIPLATIN + MDG |